Last updated: 29 days ago
AstraZeneca PLC Shareholding Update: Pascal Soriot's Vested Shares Report (May 2025)
AstraZeneca's Form 6-K reveals CEO Pascal Soriot's acquisition of 8,970 shares post-vesting. Key insights on performance, compliance, and tax obligations included.